Skip To Content
bool(false)

What’s new in clinical trials in 2022? A Q&A with retinal specialists Dr. Héon and Dr. Koenekoop

As we start a new year we asked Drs. Elise Héon and Robert Koenekoop to share their insight on what treatment advances we may see for inherited retinal diseases in 2022. Dr….

Learn

Fighting Blindness Canada invests in cutting-edge research to develop new innovative treatments for blinding eye diseases and is committed to ensuring that those treatments reach the people who need them. To keep…

Clinical Trials

On this page you can find a list of clinical trials for inherited retinal diseases, such as retinitis pigmentosa and Stargardt disease, as well as for some innovative treatments for age-related macular…

Restore Vision 20/20 Research Awards: Developing Treatments to Restore Sight

In 2018 Fighting Blindness Canada (FBC) announced the first Restore Vision 20/20 research awards which support world-class research teams to develop therapeutic approaches for late-stage retinal degeneration, specifically retinitis pigmentosa (RP). Through…

Your impact: How FBC funded research is leading the way to new treatments for retinal degeneration

Until recently there were no treatments for inherited retinal diseases (IRDs) but investments in research over the past decades have started to pay off. Treatments are now being tested and, in the…

FBC Featured on AMI’s ‘The Pulse’ Podcast

Fighting Blindness Canada (FBC) is a proud partner of Accessible Media Inc. (AMI). To support Canadians living with vision loss by providing eye health information and educational resources, FBC and AMI collaborated…

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy